Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Cancers|July 2, 2021
Genetic Characterization and Clinical Features of Helicobacter pylori Negative Gastric Mucosa-Associated Lymphoid Tissue LymphomaBarbara Kiesewetter, Christiane Copie-Bergman, Michael Levy, et al.
British Journal of Haematology|August 4, 2017
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO)Eric Durot, Cécile Tomowiak, Anne-Sophie Michallet, et al.
European Journal of Haematology|April 16, 2019
Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphomaEtienne Crickx, Elsa Poullot, Guillaume Moulis, et al.
Cancer Medicine|July 26, 2020
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trialsMarc P E André, Patrice Carde, Simonetta Viviani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association StudyRené-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice, et al.
Haematologica|May 31, 2022
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baselineCédric Rossi, Marc André, Jehan Dupuis, et al.
Plos One|June 4, 2016
In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin LymphomasDanielle Canioni, Jean-Marie Michot, Pascaline Rabiega, et al.
Annals of Hematology|January 26, 2021
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohortFlorian Bouclet, Anne Calleja, Marie-Sarah Dilhuydy, et al.
American Journal of Hematology|June 10, 2018
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centersCédric Rossi, Julia Gilhodes, Marie Maerevoet, et al.
American Journal of Hematology|November 25, 2014
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C studyJean-Marie Michot, Danielle Canioni, Henda Driss, et al.
Pageof 9